Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (120)

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors)

    Virchows Archiv, Vol. 482, Núm. 3, pp. 615-623

2022

  1. Changes and Perspectives in the New 2022 WHO Classification of Thyroid Neoplasms

    Revista Espanola de Patologia

  2. Histopathological Features of Pendred Syndrome Thyroids Align with Differences in the Expression of Thyroid-Specific Markers, Apical Iodide Transporters, and Ciliogenesis Process

    Endocrine Pathology, Vol. 33, Núm. 4, pp. 484-493

  3. Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys

    Frontiers in Endocrinology, Vol. 13

2021

  1. Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer

    Scientific Reports, Vol. 11, Núm. 1

  2. Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates

    Endocrine Pathology, Vol. 32, Núm. 1, pp. 77-101

  3. Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification

    Endocrine Pathology, Vol. 32, Núm. 1, pp. 44-62

  4. Pathological thyroid findings in amiodarone-induced thyrotoxicosis

    Revista Espanola de Patologia, Vol. 54, Núm. 2, pp. 123-126

  5. Protein Extraction From FFPE Kidney Tissue Samples: A Review of the Literature and Characterization of Techniques

    Frontiers in Medicine, Vol. 8

  6. Rate of non-invasive follicular thyroid neoplasms with papillary-like nuclear features depends on pathologist’s criteria: a multicentre retrospective Southern European study with prolonged follow-up

    Endocrine, Vol. 73, Núm. 1, pp. 131-140

  7. The Authors Reply PMC and PMT: Real Medicine and Not Just Biology

    American Journal of Surgical Pathology

2020

  1. A novel nanoproteomic approach for the identification of molecular targets associated with thyroid tumors

    Nanomaterials, Vol. 10, Núm. 12, pp. 1-20

  2. GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells

    Frontiers in Endocrinology, Vol. 11

  3. Lat-1 and glut-1 carrier expression and its prognostic value in gastroenteropancreatic neuroendocrine tumors

    Cancers, Vol. 12, Núm. 10, pp. 1-18

  4. Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers

    Endocrine Pathology, Vol. 31, Núm. 3, pp. 197-217

  5. Thyroid papillary microtumor: Validation of the (updated) porto proposal assessing sex hormone receptor expression and mutational BRAF gene status

    American Journal of Surgical Pathology, Vol. 44, Núm. 9, pp. 1161-1172

  6. Tumors of the thyroid gland. Proposal for the management and study of samples from patients with thyroid neoplasms

    Revista Espanola de Patologia, Vol. 53, Núm. 1, pp. 27-36